tradingkey.logo

Transcode Announces The Acquisition Of Polynoma And A $25 Mln Financing By Subsidiary Of CK Life Sciences

ReutersOct 8, 2025 12:24 PM

- Transcode Therapeutics Inc RNAZ.O:

  • TRANSCODE THERAPEUTICS (RNAZ) ANNOUNCES THE ACQUISITION OF POLYNOMA AND A $25 MILLION STRATEGIC FINANCING BY A SUBSIDIARY OF CK LIFE SCIENCES TO FORM A FIRST-IN-CLASS UNIQUE IMMUNO-ONCOLOGY AND METASTATIC PREVENTION ONCOLOGY COMPANY

  • TRANSCODE THERAPEUTICS INC - CONCURRENT EQUITY INVESTMENT OF $25 MILLION FROM CK LIFE SCIENCES INTO TRANSCODE

  • TRANSCODE THERAPEUTICS INC: PHILIPPE CALAIS APPOINTED AS TRANSCODE'S CHIEF EXECUTIVE OFFICER AND REMAINS CHAIRMAN

  • TRANSCODE THERAPEUTICS INC: TOM FITZGERALD STEPS DOWN AS INTERIM CHIEF EXECUTIVE OFFICER BUT REMAINS CHIEF FINANCIAL OFFICER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI